Search Results - "Sakharova, K. V."

Clinical picture of ankylosing spondylitis in HLA-B27 positive and negative patients by Erdes, Sh. F., Sakharova, K. V.

“…   The link between the HLA-B27 gene and ankylosing spondylitis (AS) has been known for almost 50 years. During this time, it has been discovered that some of…”
Get full text

Clinical features of patients with ankylosing spondylitis with inefficacy of two or more biological disease modifying antirheumatic drugs by Erdes, Sh. F., Sakharova, K. V., Dubinina, T. V., Cherkasova, M. V.

“…The “Treat-to-target” (T2T) strategy for axial spondyloarthritis (axSpA) has made it possible to optimize therapy in most patients, but in some of them the…”
Get full text

Serum amyloid A as a marker of ankylosing spondylitis activity by Sakharova, K. V., Cherkasova, M. V., Erdes, Sh. F.

“…Serum amyloid A protein A (SAA) is a normal serum protein (serving as a precursor of fibrillar tissue protein AA), synthesized in the liver and a rapidly…”
Get full text

Assessment of spine mobility in patients with ankylosing spondylitis by ultrasound scanning (preliminary data) by Kurbanmagomedov, M. K., Sakharova, K. V., Demina, A. B., Erdes, Sh. F.

“…Spine involvement in ankylosing spondylitis (AS) resulting in limited mobility requires a search for accurate, quantitatively methods of assessment of the…”
Get full text

The effectiveness of switching from an originator biological agent to its biosimilar, or vice versa, for ankylosing spondylitis in real clinical practice by Sakharova, K. V., Podryadnova, M. V., Erdes, Sh. F.

“…If standard therapy with nonsteroidal anti-inflammatory drugs is ineffective, biological drugs are usually prescribed for patients with active ankylosing…”
Get full text

The development of universal alopecia during therapy with TNF-α inhibitors in patients with ankylosing spondylitis: description of three cases by Kireeva, M. V., Agafonova, E. M., Dimitreva, A. E., Sakharova, K. V., Krasnenko, S. O., Erdes, Sh. F.

“…Alopecia areata (АA) is an autoimmune multifactorial disease characterized by increased hair loss as a result of morphological and functional changes in hair…”
Get full text

Involvement of polymorphisms of TNF, CRP and SAA1 genes in the predisposition to the development of ankylosing spondylitis and its clinical manifestations by Krylov, M. Yu, Guseva, I. A., Sakharova, K. V., Samarkina, E. Yu, Erdes, S. F., Konovalova, N. V., Varlamov, D. A.

“…Objective. To study the involvement of the rs1800629 G/A polymorphisms of the TNF-α gene, rs1205C/T of the CRP gene, and rs12218T/C of the SAA1 gene in the…”
Get full text

Validation of the Russian-language version of Ankylosing Spondylitis Quality of Life (ASQoL) questionnaire by L. D. Vorobyova, T. V. Dubinina, A. O. Sablina, A. B. Demina, E. V. Ilinykh, K. V. Sakharova, I. A. Andrianova, T. V. Korotaeva, L. V. Ivanova

“…Objective: validation of the Russian-language version of Ankylosing Spondylitis Quality of Life (ASQoL) specific questionnaire for patients with ankylosing…”
Get full text